Dual-Source CT Coronary Angiogram in Heart Transplant Recipients in Comparison With Dobutamine Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy

被引:23
|
作者
Mastrobuoni, Stefano [1 ]
Bastarrika, Gorka [2 ]
Ubilla, Matias [1 ]
Castano, Sara [3 ]
Azcarate, Pedro [3 ]
Barrero, Eduardo Alegria [3 ]
Castellano, Jose Maria [3 ]
Herreros, Jesus [1 ]
Rabago, Gregorio [1 ]
机构
[1] Univ Navarra, Univ Navarra Clin, Dept Cardiovasc Surg, Pamplona 31008, Spain
[2] Univ Navarra, Univ Navarra Clin, Dept Radiol, Pamplona 31008, Spain
[3] Univ Navarra, Univ Navarra Clin, Dept Cardiol, Pamplona 31008, Spain
关键词
Dual-source computed tomography; CAV; Cardiac recipient; INTRAVASCULAR ULTRASOUND; COMPUTED-TOMOGRAPHY; ARTERY-DISEASE; IMAGE QUALITY; RECONSTRUCTION; MANAGEMENT;
D O I
10.1097/TP.0b013e318195a5a7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Conventional coronary angiography (CCA) is the gold standard in the diagnosis of cardiac allograft vasculopathy (CAV) in heart transplant recipients. Dobutamine stress echocardiography (I)SE) is a useful technique for screening. Dual-source computed tomography (DSCT) is the last generation of computed tomography scanners, which could be useful to noninvasively assess CAV. Thirty cardiac transplant recipients underwent DSE and DSCT coronary angiogram. Exclusion criteria were as follows: renal insufficiency, iodinated contrast media allergy, less than 12 months since transplant, and unstable clinical conditions. DSE showed ischemia in two patients. At DSCT scan 13 patients had a normal angiogram, 13 ones wall thickening and four significant diseases. DSCT showed a sensitivity of 100% with a specificity of 92%. DSCT allowed detection of more patients with CAV than DSE. Four patients showed significant CAV at DSCT compared with two at DSE. Thirteen patients showed initial signs of disease at DSCT despite a normal DSE.
引用
收藏
页码:587 / 590
页数:4
相关论文
共 50 条
  • [21] Preoperative coronary risk assessment with dual-source CT in patients undergoing noncoronary cardiac surgery
    Buffa, V.
    De Cecco, C. N.
    Cossu, L.
    Fedeli, S.
    Vallone, A.
    Ruopoli, R.
    Luzietti, M.
    Angelica, G.
    David, V.
    Musumeci, F.
    RADIOLOGIA MEDICA, 2010, 115 (07): : 1028 - 1037
  • [22] Application of Dual-Source CT Coronary Angiography in Type 2 Diabetic Patients with Symptomatic Coronary Heart Disease
    He, Ci
    Wang, Peng
    Du, Fei-Zhou
    Yang, Zhi-Gang
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (01) : 59 - 65
  • [23] Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors
    Kadosh, Bernard S.
    Birs, Antoinette S.
    Flattery, Erin
    Stachel, Maxine
    Hong, Kimberly N.
    Xia, Yuhe
    Gidea, Claudia
    Aslam, Saima
    Razzouk, Louai
    Saraon, Tajinderpal
    Goldberg, Randal
    Rao, Shaline
    Pretorius, Victor
    Moazami, Nader
    Smith, Deane E.
    Adler, Eric D.
    Reyentovich, Alex
    CLINICAL TRANSPLANTATION, 2024, 38 (04)
  • [24] Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients
    Broch, Kaspar
    Lemstrom, Karl B.
    Gustafsson, Finn
    Eiskjaer, Hans
    Karason, Kristjan
    Gjesdal, Grunde
    Fagerland, Morten W.
    Pentikainen, Markku
    Lommi, Jyri
    Gude, Einar
    Andreassen, Arne K.
    Clemmensen, Tor S.
    Christiansen, Evald H.
    Bjorkelund, Elisabeth
    Berg, Erlend S.
    Arora, Satish
    Gullestad, Lars
    JACC-HEART FAILURE, 2024, 12 (10) : 1677 - 1688
  • [25] Multiparametric quantitative structural and functional cardiac MRI in orthotopic heart transplant recipients with cardiac allograft vasculopathy
    Quinn, Sandra
    Sarnari, Roberto
    Zbihley, Andrew
    Sherlock, Daniel
    Raikar, Connor
    Engel, Joshua
    Pedamallu, Havisha
    Lin, Kai
    Ghafourian, Kambiz
    Lee, Daniel C.
    Vorovich, Esther E.
    Yancy, Clyde W.
    Rigolin, Vera H.
    Lomasney, Jon W.
    Carr, James C.
    Allen, Bradley D.
    Markl, Michael
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2025,
  • [26] Coronary computed tomography in heart transplant patients: detection of significant stenosis and cardiac allograft vasculopathy, image quality, and radiation dose
    Gunther, Anne
    Aaberge, Lars
    Abildgaard, Andreas
    Ragnarsson, Asgrimur
    Edvardsen, Thor
    Jakobsen, Jarl
    Andersen, Rune
    ACTA RADIOLOGICA, 2018, 59 (09) : 1066 - 1073
  • [27] Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients
    Nous, Fay M. A.
    Roest, Stefan
    van Dijkman, Eva D.
    Attrach, Mohamed
    Caliskan, Kadir
    Brugts, Jasper J.
    Nieman, Koen
    Hirsch, Alexander
    Constantinescu, Alina A.
    Manintveld, Olivier C.
    Budde, Ricardo P. J.
    TRANSPLANT INTERNATIONAL, 2021, 34 (10) : 1886 - 1894
  • [28] Long-term efficacy of everolimus as de novo immunosuppressant on the cardiac allograft vasculopathy in heart transplant recipients
    Choi, Hyo-In
    Kang, Do-Yoon
    Kim, Min-Seok
    Lee, Sang Eun
    Ahn, Jung-Min
    Lee, Jong-Young
    Kim, Yong-Hak
    Park, Duk-Woo
    Jung, Sung-Ho
    Kim, Jae-Joong
    ATHEROSCLEROSIS, 2022, 357 : 1 - 8
  • [29] Dual-source CT coronary angiography without heart rate or rhythm control in comparison with conventional coronary angiography
    Xiang Ming Fang
    Hong Wei Chen
    Xiao Yun Hu
    Jian Bao
    Yin Chen
    Zhen Yu Yang
    Orla Buckley
    Xiao Qing Wu
    The International Journal of Cardiovascular Imaging, 2010, 26 : 323 - 331
  • [30] Risk Stratification for Cardiac Allograft Vasculopathy in Heart Transplant Recipients - Annual Intravascular Ultrasound Evaluation
    Sato, Takuma
    Seguchi, Osamu
    Ishibashi-Ueda, Hatsue
    Yanase, Masanobu
    Okada, Norihiro
    Kuroda, Kensuke
    Hisamatsu, Eriko
    Sunami, Haruki
    Watanabe, Takuya
    Nakajima, Seiko
    Wada, Kyoichi
    Hata, Hiroki
    Fujita, Tomoyuki
    Fukushima, Norihide
    Kobayashi, Junjiro
    Nakatani, Takeshi
    CIRCULATION JOURNAL, 2016, 80 (02) : 395 - 403